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Long-term safety of left renal vein division
and ligation to expedite complex abdominal
aortic surgery
Russell H. Samson, MD, Michael R. Lepore Jr, MD, David P. Showalter, MD, Deepak G. Nair, MD, and
Julien B. Lanoue, Sarasota, Fla
Background: Left renal vein division and ligation (LRVDAL) is performed to facilitate complex abdominal aortic surgery.
Surgeons restore continuity of the vein due to concern that ligation could cause renal compromise or hematuria.
However, we report the short and long-term safety of left renal vein division and ligation.
Method: Between 1992 and 2007, we divided the left renal vein in 56 patients (40 males, 16 females) ages 57 to 84
(average 74-years-old) who were treated for aortic occlusive disease (9) or abdominal aortic aneurysm (47). Patients
requiring concomitant renal artery reconstruction were excluded from this review. Suprarenal cross-clamp was used in 51
patients with temporary vessel-loop control of the renal arteries. Creatinine (Cr) and glomerular filtration rates (eGFR)
were measured pre-, post-, and long-term after surgery. Outpatient records of all patients that had survived more than 12
months were also reviewed in order to evaluate the late effects on renal function or symptoms possibly related to
LRVDAL.
Results: Median procedure duration was 157 (61-375) minutes. Median cross-clamp time was 16 (10-45) minutes.
Median intensive care unit (ICU) and hospital length of stays were 2 (1-11) days and 7 (4-58) days, respectively. There
were no deaths. There were no complications directly related to renal vein ligation. Hematuria, seen in 2 patients, was a
result of traumatic insertion of a Foley catheter. Median pre-op and discharge Cr levels were 1.1 mg/dL (0.7-2.4 mg/dL)
and 1.1 mg/dL (0.6-2.1 mg/dL), respectively (P < .5). Median change in Cr was 0.0 mg/dL and only increased in 14
patients (maximum increase 0.9 mg/dL). Median pre-op and discharge eGFR was 61 mL/minute (28-137 mL/minute/
1.73 m2) and 67 mL/minute (32-138 mL/minute/1.73 m2), respectively (P< .5). Cr and eGFR in the 2 patients with
a Cr of >2.0 mg/dL remained unchanged post-op. Only 2 patients with a Cr of <2.0 mg/dL had a post-op Cr >2.0
mg/dL and both returned to normal by day 3 post-op. Thirty-six patients have been followed for more than a year
(median 34.5 months, maximum 144 months) and Cr has remained stable in all but 2 patients. These 2 patients, both
with a pre-op Cr of 1.5 mg/dL, subsequently developed Cr levels of 2.1 mg/dL and 2.4 mg/dL but maintained baseline
Cr levels for 25 and 34months, respectively, before demonstrating these elevated levels which have proven to be unrelated
to renal vein ligation. Hematuria and flank pain have never been recorded after discharge.
Conclusion: Restoration of left renal vein continuity after LRVDAL may be unnecessary since renal compromise and
hematuria was not encountered in this long-term analysis. ( J Vasc Surg 2009;50:500-4.)Endovascular techniques have allowed the vascular sur-
geon to treat most patients whose aortic occlusive or aneu-
rysmal disease is associated with favorable anatomy. During
this paradigm shift, we, as well as others, have seen an
increase in the complexity of open aortic reconstruction1
due to heavily calcified aortas or those with wide, angled,
short, or absent aortic necks. Accordingly, safe surgery will
frequently now demand excellent exposure of the juxta-
renal aorta. In order to better visualize this anatomic re-
gion, we have increasingly adopted the technique of left
renal vein (LRV) ligation and division (left renal vein
division and ligation [LRVDAL]) which was first described
by Neal and Shearburn in 1967.2 Left renal vein division
and subsequent re-anastomosis (LRVDAR) in order to
facilitate such exposure was originally described by Szilagyi
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500et al3 and this technique has been adopted by many sur-
geons. However, since then there have been reports attest-
ing to the safety of LRVDAL although there have also been
manuscripts suggesting that failure to reconstruct the left
renal vein could lead to deterioration in renal function as
well as other untoward complications.
In an attempt to determine whether LRVDAL has any
potential adverse sequelae, we have performed a retrospec-
tive review of our experience. Our manuscript is unique in
that it is the first to evaluate not only in-hospital creatinine
(Cr) and estimated glomerular filtration rates (eGFR) levels
but also the long term consequences of LRVDAL.
MATERIALS AND METHODS
From August 1992 through December 2007, 1012
patients underwent open aortic surgery. In order to prevent
compounding variables, patients who underwent concom-
itant renal artery reconstruction were excluded from this
review, except for 1 patient who had an aberrant secondary
right renal artery re-anastomosed to the aortic graft at the
time of the procedure. Fifty-six of these patients required
concomitant LRVDAL in order to enable improved expo-
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occlusive disease (9) or abdominal aortic aneurysm (47).
LRVDAR was never performed. All procedures were per-
formed by one of three board certified vascular surgeons as
the primary surgeon. Typically, two of the three surgeons
worked together using a standard transabdominal/trans-
peritoneal approach. The renal arteries were controlled
with vessel loops to prevent atheroembolization whenever
suprarenal cross-clamping was required (51 of 56 patients).
The left renal vein was ligated and then suture ligated with
2.0 silk before being divided close to the inferior vena cava
in an attempt to preserve collateral venous drainage to the
left kidney. The major tributaries, ie, the gonadal, adrenal,
and lumbar veins were preserved in all patients. Also, the
right kidney and its renal vein were anatomically normal in
all patients. All patients were heparinized prior to aortic
cross-clamping, and reversed with protamine sulphate at
the end of the procedure. Mannitol (12.5 grams) was given
in all cases prior to aortic cross-clamping. Standard cell
saver collection and reinfusion techniques were used in
most cases. Aortic reconstruction was performed in all cases
with woven polyester Dacron grafts.
A retrospective review of hospital records was per-
formed with attention to operative reports, pre- and post-
operative labs, and perioperative complications. Operative
times and blood loss were recorded for all operations.
Demographic data was also collected including: age, gen-
der, tobacco use, coronary artery disease, hypercholesterol-
emia, diabetes, chronic obstructive pulmonary disease,
peripheral arterial disease, hypertension, and renal insuffi-
ciency (Cr 1.5 gm/dL). Preoperative, in-hospital, and
discharge Cr and eGFR were recorded. The eGFR was
calculated using the Cockcroft-Gault equation4,5 (140-
age)weight/72 serumCr (age is in years, body weight
is in kilograms, and serum Cr is in mg/dL; in women, the
equation is multiplied by 0.85). The eGFR values are
expressed as mL/minute/1.73 m2. Outpatient records of
all patients that had survived more than 12 months were
also reviewed in order to evaluate late effects on renal
function or symptoms possibly related to LRVDAL.
All in-hospital complications were recorded using the
following criteria: blood transfusions that were required in
the postoperative course, stroke, pulmonary embolism, or
deep venous thrombosis as documented by computed to-
mographic angiography (CTA) scan and/or venous duplex
ultrasound scan or d-dimer elevation when the diagnosis
required laboratory confirmation, myocardial infarction as
documented by electrocardiographic changes and enzy-
matic elevation, electrocardiogram (EKG) evidence of ar-
rhythmias, congestive heart failure identified by discharge
diagnosis and documented by cardiology consultation, he-
maturia confirmed by urine analysis, renal failure (Cr 2.0
mg/dL), ileus defined as inability to advance diet by post-
operative day (POD) #3, respiratory complications if the
patient could not be extubated within 24 hours, required
reintubation, developed pneumonia, or required a trache-
ostomy. Hospital and intensive care unit (ICU) length of
stay were also recorded.RESULTS
There were 56 patients (males 40 [71%], females 16
[29%]) reviewed for this study. Mean age was 74 years
(range, 57-84 years). Comorbidities are listed in Table I.
Significantly, coronary artery disease (CAD) was present in
36 (64%) patients and hypertension was prevalent (68%).
Baseline renal insufficiency (Cr1.5 mg/dL) was noted in
8 (14%) of the patients.
Because of short aortic necks or heavy infrarenal aortic
calcification, the majority of the patients (51 [91%]) under-
went suprarenal aortic cross-clamping. Median suprarenal
cross-clamp time was 16 minutes (range, 10-45). Median
operative time was 157 minutes (range, 61-375). Median
blood losswas 1125mL (range, 250-3000mL).Median ICU
stay was 2 days (range, 1-11 days) with median overall length
of stay 7 days (range, 4-58).
In-hospital morbidity andmortality. There were no
deaths in our patient cohort (Table II). There were no
strokes, pulmonary embolisms, or limbs lost. Seven (13%)
total patients experienced delayed return of bowel function
lasting 3 days postoperatively (range, 4-7 days). Cardiac
complications occurred in 8 (14%) patients, arrhythmias 5
(9%), myocardial infarction 1 (2%), and congestive heart
failure 2 (4%). Five patients (9%) experienced respiratory
Table I. Comorbidities encountered in the 56 patients
undergoing left renal vein division and ligation
Comorbidities Patients, n (%)
CAD 36 (64%)
Hypertension 38 (68%)
Tobacco 28 (56%)
Hypercholesterolemia 31 (55%)
Peripheral arterial disease 35 (63%)
Diabetes 10 (18%)
Pulmonary disease 22 (39%)
Renal insufficiency (Cr 1.5 mg/dL) 8 (14%)
CAD, Coronary artery disease; Cr, creatinine.
Table II. Complications following aortic surgery in the
56 patients with concomitant left renal vein division and
ligation
Complication Patients, n (%)
Deaths 0 (0%)
Strokes 0 (0%)
Pulmonary embolism 0 (0%)
Limb loss 0 (0%)
Renal failure (Cr 2.0 mg/dL) 1 (2%)
Hematuria 2 (4%)
Respiratory 5 (9%)
Ileus 7 (13%)
Total cardiac 8 (14%)
Arrhythmias 5 (9%)
MI 1 (2%)
CHF 2 (4%)
Cr, Creatinine; MI, myocardial infarction; CHF, congestive heart failure.complications, but only 1 required a tracheostomy. Hema-
on rat
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patients had traumatic Foley catheter insertions and cleared
their urine within 72 hours.
Cr and eGFR. Average and median preoperative Cr
was 1.13 mg/dL and 1.1 mg/dL, respectively, (range,
0.7-2.4 mg/dL). Calculated preoperative average eGFR
was 66.3 mL/minute/1.73 m2 with a median of 60.7
mL/minute/1.73 m2 (range, 28.0-137.0 mL/minute/
1.73 m2). Median change in Cr was 0.0 mg/dL and only
increased in 14 patients (maximum increase 0.9 mg/dL).
Median Cr at discharge was similar to pre-op (1.1 mg/dL
[0.6-2.1 mg/dL]). Median eGFR increased from 60.7
(range, 28.1-137.1) to 66.8 (32.1-138.0) mL/minute/
1.73 m2 but this was not significant (P .5) (see Table III
and the Fig). Eight patients (14%) were considered to have
renal insufficiency preoperatively defined as aCr1.5mg/dL
(median Cr 1.6 mg/dL; range, 1.5 to 2.4 mg/dL), yet 5
patients demonstrated a decrease in Cr and a concomitant
increase in eGFR to normal levels postoperatively. Further,
only 1 of these 8 patients had an increase in Cr (from 1.6
mg/dL to2.3mg/dLonPOD#3).Hewas dischargedhome
at POD#6with a Cr of 1.8mg/dL. The other 2 patients also
had discharge Cr lower than preoperative values (1.6 mg/dL
Table III. Creatinine levels and glomerular filtration rates
Test Pre-op POD #1
Cr (mg/dL) 1.1 (0.7-2.4) 1.1 (0.7-2.1)
eGFR (mL/minute) 60.7 (28.0-137.0) 63.7 (36.6-120.7
POD, Postoperative day; Cr, creatinine; eGFR, estimated glomerular filtrati
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Fig. Graph of the in-hospital creatinine levels of the 36
12 months.to 1.5mg/dL and 2.4mg/dL to 1.5mg/dL). The Cr valuesfor these 8 patient pre- and postoperatively were 1.6 to 1.5,
1.8 to 1.2, 1.5 to 1.0, 1.5 to 1.2, 1.6 to 1.1, 1.5 to 1.2, 2.4 to
1.5, and 1.6 to 1.8. The 3 patients with an eGFR of 30
mL/minute/1.73m2 all improved their eGFR to values30
mL/minute/1.73 m2 at discharge.
There was only 1 patient in the study who was dis-
charged with a Cr 2.0 mg/dL. The preoperative Cr was
1.2 mg/dL, increased on POD #2 to 1.9 mg/dL, and 2.1
mg/dL at discharge. This patient’s operation was compli-
cated by a known left kidney malignancy requiring subse-
quent nephrectomy and a 5 mm accessory right lower pole
renal artery that was reimplanted into the aortic graft (total
suprarenal cross-clamp time was 30 minutes).
Long-term follow-up (12 months after the original
surgery) has been obtained in 36 patients (minimum 12
months, median 34.5 months, maximum of 144 months).
Median Cr was 1.1 mg/dL preoperatively and postopera-
tively. Median preoperative eGFR was 61.2 mL/minute/
1.73m2 and increased to 64.7mL/minute/1.73m2 postop-
eratively. Six patients satisfying this criterion have been lost to
follow-up. All of the patients, except 2, have maintained their
baseline Cr and eGFR levels. Both of these patients had
preoperative Cr levels of 1.5 mg/dL and maintained
POD #2 POD #3 Discharge
1.1 (0.7-2.4) 1.1 (0.7-2.3) 1.1 (0.6-2.1)
64.4 (30.4-138.0) 66.4 (34.7-137.4) 66.8 (32.1-138.0)
e.
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Nephrology consultation suggests that these changes
were due to intrinsic hypertensive nephrosclerosis and
were unrelated to renal vein ligation or renal artery
stenosis. None of the 36 patients have developed macro
or microscopic hematuria and none have reported left
flank pain.
DISCUSSION
The complexity of open aortic surgery will continue to
increase as endovascular aortic techniques and devices con-
tinue to improve. Hence vascular surgeons performing
open surgery on the abdominal aorta will more frequently
be challenged by short, wide, calcified, or otherwise hostile
juxta-renal aortic necks. Temporary division of the LRV has
been described as one technique to enhance exposure and
control of the juxtarenal aorta and this technique is increas-
ingly being utilized. What remains controversial is whether
continuity of the vein needs to be restored since collateral
flow is usually preserved through the phrenic, gonadal,
adrenal, and lumbar veins provided that these veins are not
also divided or absent. Proponents of LRVDAL have de-
scribed it as a safe adjunct to aortic surgery6 without
significant in-hospital deterioration in renal function.7,8,9
However, other authors have opposed LRVDAL and re-
ported renal derangements such as an increase in BUN/Cr,
decrease in eGFR, venous congestion causing kidney swell-
ing, and sometimes capsular rupture.10-14
In order to determine whether the vein could be di-
vided and safely ligated, Calligaro et al15 described “test
clamping” the renal vein to check stump pressures. They
suggested that when the LRV is distended and stump
pressure is 50 cm water, renal vein ligation and division
should not be attempted, rather relying on re-anastomosis or
retraction of the vein which can be mobilized more readily by
ligating the gonadal vein. More recently, there have been
further recommendations that the LRV should be recon-
structed after temporary division.16 However, it has been our
experience that re-anastomosis is not only unnecessary, but
increases both operative time and potential blood loss in an
already complex operation. The benefit of LRVDAL on these
aspects of the perioperative experience cannot be assessed
from this study since we have no valid personal comparison to
surgery without this maneuver. However, we believe that the
0% mortality, short cross-clamp times, standard blood loss,
and short ICU and hospital stays all attest to excellent expo-
sure afforded by LRDVAL.
Importantly, our series of 56 patients who had
LRVDAL failed to demonstrate any significant deteriora-
tion in renal function either early or late. Further, although
not statistically significant, median discharge eGFR in-
creased slightly in the overall study population and all but 1
of the patients who had renal insufficiency (Cr 1.5 mg/
dL) experienced a decrease in Cr and an increase in eGFR.
This was likely secondary to aggressive perioperative hydra-
tion in combination with relatively short suprarenal aortic
cross-clamp times. Only 1 patient experienced a clinically
significant increase in Cr and decrease in eGFR, but thatpatient had a malignant tumor in the left kidney and
required accessory lower pole arterial re-anastomosis to the
graft. These findings are even more convincing when con-
sidering that 51 (91%) of the patients also had suprarenal
cross-clamp application with vessel loop temporary control
of renal artery blood flow in conjunction with LRV divi-
sion, a combination that is thought to be detrimental to
renal function. However, we believe that vessel loop con-
trol of the renal arteries is critical to prevent atheroembo-
lism and consider it possible that failure to use this protec-
tive method may account for renal failure sometimes
reported in other manuscripts dealing with LRVDAL.
Further, unlike previous reports on the subject, we have
been able to follow 36 patients for more than a year after
LRVDAL to evaluate if there were any long-term effects on
renal function. Thirty-four showed no change in renal
function and the 2 patients that did develop elevation in Cr
and decreasing eGFR both had this occur more than a year
after surgery and unrelated to renal vein ligation. Another
theoretical long-term risk of LRVDAL is the development
of perinephric venous dilation, varicosities, and ultimately
hematuria. This has been described in patients who have
the so-called “nutcracker syndrome” ostensibly due to
compression of the left renal vein against the aorta by the
superior mesenteric artery.17,18 These patients may experi-
ence left flank pain with radiation to the left buttock, pelvic
pain, and hematuria. Treatment by either stenting tech-
niques or left renal vein transposition have been de-
scribed.19,20 However, none of the 36 patients followed
long-term have developed any similar symptoms or find-
ings. The only hematuria that our patients experienced
appeared to be secondary to trauma from Foley catheter
insertion at the time of surgery. We have no explanation for
the lack of such venous congestion complications other
than to suggest that surgical division immediately next to
the inferior vena cava spares collaterals that may be im-
pinged by the superior mesenteric artery in the “nutcracker
syndrome” or that patients with this syndrome have some
other abnormality of renal venous drainage.
There are potential shortcomings of our review. Only 3
patients had a preoperative eGFR of 30 mL/minute/
1.73 m2. Although all 3 patients and the other 5 patients
who had eGFR 30 mL/minute/1,73 m2 but a Cr of
1.5mg/dL all improved their renal function at discharge,
it is possible that LRVDALmay not be safe in this subset of
renal impaired patients. Also, urinalysis was only performed
when hematuria was suspected so long-term microscopic
hematuria may have been present in some of the patients.
CONCLUSION
The LRV can be readily divided adjacent to the inferior
vena cava in order to provide improved exposure during
complex aortic reconstruction. In our series, suprarenal cross-
clamping with temporary cessation of renal blood flow in
combination with permanent LRVDAL did not appear to
adversely affect early or late renal function. Theoretical disad-
vantages of renal vein ligation such as flank pain or hematuria
also were not noted in this series. Accordingly, we now have a
JOURNAL OF VASCULAR SURGERY
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exposure of the juxtarenal aorta is required.
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Dr Randolph L. Geary (Winston-Salem, NC). Dr Samson
and colleagues are to be congratulated for a provocative presenta-
tion and excellent clinical results in a challenging group of patients.
This topic is controversial and the literature fairly evenly split with
half of the largest case series arguing left renal vein ligation is safe
and the other half concluding the vein should be kept in continuity
to avoid renal insufficiency, hematuria, or pelvic venous conges-
tion. Our bias at Wake Forest is that mobilizing the vein and
dividing its various tributaries provides excellent exposure of the
peri-renal aorta in all but a handful of cases. In our last 200 aortic
reconstructions, I could find only four cases in which the left renal
vein was divided and in two cases the vein was subsequently
repaired. This brings me tomy first question. In your opinion, how
often is dividing the vein simply a convenience rather than a
requirement to safely complete the operation? Do you divide the
vein in every case requiring supra-renal aortic control or are these
56 cases a subset of the total requiring supra-renal cross-clamping
by your group during the period of study? Second, only half of
your patients contributed to the 1 year analysis. Of these, only 2
patients had a significant decline in renal function and both were
from the subset that demonstrated renal insufficiency before sur-
gery. How many of the patients with renal insufficiency at baseline
were actually captured in your 1 year analysis? If only 2, then
following the entire population out to 1 year may change yourof patients had transient renal failure in the perioperative period.
Do the authors know whether transient renal dysfunction contrib-
uted to the length of stay or perhaps an increased number of
cardiopulmonary complications? Again, I congratulate the authors
on their excellent clinical results and thank them for bringing this
controversial topic to our attention.
Dr Samson. Thank you for your questions, I am going to
answer the last one first. I do not have the data to show whether
their transient increase influenced the length of stay and it is
something that we will look at and perhaps include in the manu-
script. As far as whether we ligate the renal vein only when it is
technically necessary or whether we have a low threshold – origi-
nally, in the study, obviously we ligated it only when we felt it was
necessary. Now we say, if you don’t mind me being somewhat
sarcastic, “hey look there is the renal vein, let’s go ligate it”,
because we really do believe that it gets in the way and prevents
operating on a more normal aorta. In our opinion, ligation of the
renal vein is the key to safe aortic surgery and all the problems that
occur with aortic surgery occur when you try to operate to a
diseased aorta. So we now ligate the left renal vein with impunity.
The other problem with trying to preserve the renal vein and
simply ligating its tributaries is that if you don’t get a good view
having done that, you are then with your back against the wall
because you can no longer ligate the vein. So we would much
prefer to just ligate the vein at that time. Finally, all 8 patients with
baseline renal failure were captured in the long-term follow-up.
